Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Abstract Background Mother-to-child transmission (MTCT) is one of the main routes of transmission of HBV, and previous studies focused on the efficacy and safety of nucleoside analogues (NAs) in preventing MTCT. There are limited data on virologic changes of chronic hepatitis B (CHB) patients after...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Qiao Tang, Chunrui Wang, Hu Li, Zhiwei Chen, Li Zhang, Jing Zhang, Xiaoqing Liu, Yunling Xue, Yue Qiu, Mingli Peng, Yi Zeng, Peng Hu
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	BMC 2025-02-01
Σειρά:	Virology Journal
Θέματα:	Mother-to-child transmission ALT abnormal Liver fibrosis Virologic response Treatment discontinuation
Διαθέσιμο Online:	https://doi.org/10.1186/s12985-025-02632-x

Παρόμοια τεκμήρια

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
ανά: Luisa Roade, κ.ά.
Έκδοση: (2023-10-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
ανά: Ying Yan, κ.ά.
Έκδοση: (2022-11-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
ανά: Jing Zhao, κ.ά.
Έκδοση: (2023-03-01)

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B
ανά: Riemawati A. Lesmana
Έκδοση: (2015-10-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
ανά: Tung-Hung Su, κ.ά.
Έκδοση: (2013-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
ανά: Chih-Chien Yao, κ.ά.
Έκδοση: (2017-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
ανά: Crozier Sarah, κ.ά.
Έκδοση: (2008-04-01)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
ανά: Dimitri Loureiro, κ.ά.
Έκδοση: (2019-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
ανά: Anouar Teriaky, κ.ά.
Έκδοση: (2013-01-01)

Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
ανά: Haiying Luo, κ.ά.
Έκδοση: (2023-07-01)

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
ανά: Chen-Hsuan Wu, κ.ά.
Έκδοση: (2017-04-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
ανά: Taqwa Hashim, κ.ά.
Έκδοση: (2023-12-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
ανά: Yifei Guo, κ.ά.
Έκδοση: (2023-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
ανά: Teresa Broquetas, κ.ά.
Έκδοση: (2017-01-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
ανά: Fatima A Ahmed, κ.ά.
Έκδοση: (2019-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
ανά: Erry Gumilar Dachlan, κ.ά.
Έκδοση: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
ανά: Cheng-Yuan Peng, κ.ά.
Έκδοση: (2015-04-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
ανά: Jia-Feng Wu, κ.ά.
Έκδοση: (2024-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
ανά: Shengxia Yin, κ.ά.
Έκδοση: (2023-12-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
ανά: Michel Bazinet, κ.ά.
Έκδοση: (2022-08-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
ανά: Stijn Van Hees, κ.ά.
Έκδοση: (2019-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
ανά: Romina Salpini, κ.ά.
Έκδοση: (2020-01-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
ανά: Zhan Zeng, κ.ά.
Έκδοση: (2023-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
ανά: Yan Peng, κ.ά.
Έκδοση: (2025-01-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
ανά: Meng Zhuo Cao, κ.ά.
Έκδοση: (2018-06-01)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
ανά: Gao F, κ.ά.
Έκδοση: (2021-10-01)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
ανά: Elisabetta Loggi, κ.ά.
Έκδοση: (2013-01-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
ανά: Jack Bee Chook, κ.ά.
Έκδοση: (2019-09-01)

Possible immunochemical pattern of anti-HCV, HBeAg, HBsAg HBeAb, and HIV-1 p24 in newly infected Mycobacterium pulmonary tuberculosis patients
ανά: Mathew Folaranmi Olaniyan, κ.ά.
Έκδοση: (2019-01-01)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
ανά: Won-Mook Choi, κ.ά.
Έκδοση: (2022-05-01)

Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant
ανά: T. Michler, κ.ά.
Έκδοση: (2014-04-01)

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman
ανά: M.J Zahedi, κ.ά.
Έκδοση: (2003-07-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
ανά: K. V. Zhdanov, κ.ά.
Έκδοση: (2014-09-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
ανά: Ayub Al Mamun, κ.ά.
Έκδοση: (2013-01-01)

Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
ανά: Menghui Duan, κ.ά.
Έκδοση: (2024-07-01)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
ανά: Yong Poovorawan, κ.ά.
Έκδοση: (2012-07-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
ανά: Jian Wang, κ.ά.
Έκδοση: (2024-12-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
ανά: Tai-Long Chien, κ.ά.
Έκδοση: (2016-01-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Έκδοση: (2006-01-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
ανά: Qiao Tang, κ.ά.
Έκδοση: (2024-12-01)